Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

FRESENIUS KABI PHARMA PORTUGAL LDA

NIF 504293753
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €7,294,053 119 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €7,294,053 119 contracts
A2 · Late Publication €8,764,579,416 6,658 contracts
Contract published to BASE more than 10 days after the signing date
LOW €8,764,579,416 6,658 contracts
A5 · Threshold Splitting €13,194,973 237 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €13,194,973 237 contracts
A6 · Low Competition €642,501 28 contracts
Only one bidder participated in a competitive procedure
MEDIUM €642,501 28 contracts
A9 · Price Overrun €10,356 2 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €10,356 2 contracts
A9 · Abnormal Price Reduction €10,913,762,149 3,635 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €10,913,762,149 3,635 contracts
C3 · Missing Mandatory Fields €2,574,530 174 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €2,574,530 174 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

105
€1,290,279,291
62
€538,926,641
451
€533,293,775
182
€505,558,203
79
€494,027,995
804
€445,880,145
751
€443,475,035
75
€425,762,035
44
€375,393,765
67
€367,680,536
221
€344,654,281
897
€344,402,811
104
€337,056,229
211
€337,054,236
291
€331,884,525
167
€288,618,109
44
€283,579,041
104
€279,750,321
83
€258,157,935
67
€238,778,479
Page 1 of 4 · 76 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 5 · 237 contracts

SACO QUADRUPLO C/FILTRO DESLEUCOCITAÇÃO INCORPORADO P/SANGUE 500CC - PC.00534.2026
PT · 13636846 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,152 2026-02-18
Fornecimento de fórmulas nutricionais artificial e sua distribuição e adminstrição a doentes da ULS
PT · 13319718 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€72,400 2026-02-11
4600017/2026 COSUMIVEIS PARA BOMBA INFUSORA DA FRESENIUS
PT · 12642944 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,141 2026-01-13
ADCM 0057/26 - MATERIAL DE CONSUMO CLÍNICO
PT · 13714063 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€73,827 2026-01-09
050100562026 FLUCONAZOL 2 MG/ML SOL INJ FR 200 ML IV
PT · 13149421 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,985 2026-01-06
MATERIAL DE CONSUMO CLINICO DIVERSO AA
PT · 12995191 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,700 2026-01-02
MEDICAMENTOS ANTI-INFECIOSOS (SPMS 2023/492)- PC.04305.2025
PT · 12675372 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,500 2025-12-23
41/85/2026 Medicamentos Paliperidona, Rocurónio e Ropivacaína
PT · 13147515 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,426 2025-12-04
ADCM 5038/25 - MATERIAL DE CONSUMO CLINICO
PT · 13617090 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€72,375 2025-12-02
Aquisição de Agitador e Incubadora de plaquetas, para o Serviço de Imuno - Hemoterapia, da ULSLA EPE
PT · 11946012 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,500 2025-11-12
ATOVAQUONA 150 MG/ML SUSP ORAL FR 226 ML
PT · 11948831 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,930 2025-10-24
Aquisição de Medicamentos Diversos e Nutrição
PT · 11812909 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€74,327 2025-10-17
ADCM 4198/25 - MEDICAMENTOS DIVERSOS
PT · 11819164 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€4,792 2025-10-02
Medicamentos
PT · 11906545 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€4,776 2025-10-02
Aquisição de Cisplatina 1 mg/ml sol inj fr 100 ml IV, Cisplatina 1 mg/ml sol inj fr 50 ml IV, Icatibant 30 mg/3 ml sol inj ser 3 ml SC, Oxaliplatina 5 mg/ml sol inj fr 40 ml IV e Pertuzumab 60 mg/ml + Trastuzumab 60 mg/ml sol inj fr 10 ml SC
PT · 11666422 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€73,063 2025-08-21
ADCM 3380/25 - MEDICAMENTOS DIVERSOS
PT · 11634339 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,479 2025-08-01
ADCM3064/25 - MEDICAMENTOS DIVERSOS
PT · 11616117 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€149,723 2025-07-11
ADCM 3027/25 - medicamentos diversos
PT · 11564189 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€4,881 2025-07-02
Acordo Quadro para fornecimento de Medicamentos anti-infeciosos, na área da Saúde – CP 2023/492 – SPMS
PT · 11732385 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,952 2025-06-20
DEXAMETASONA 4 MG/ML SOL INJ FR 1 ML IARTICULAR IM IV
PT · 11516958 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,992 2025-06-03
Medicamentos
PT · 11561137 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,413 2025-05-15
Aquisição de Suplementos, para a ULSASI, para o ano 2025
PT · 11461638 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication +1
€74,360 2025-05-13
ANESTESICOS LOCAIS
PT · 11428348 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€147,688 2025-05-13
Aquisição de Anti-Psicóticos, Anestésicos e Relaxantes Musculares - AQ2022/19 SPMS
PT · 11639490 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€148,515 2025-05-08
251C000060 - PARACETAMOL SOL P/ PERFUSÃO 10 MG/ML FRS
PT · 11409986 · Consulta Prévia
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€73,500 2025-05-08
Medicamentos
PT · 11371281 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€72,968 2025-04-17
ADCM 1762/25 - MEDICAMENTOS DIVERSOS
PT · 11484404 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,912 2025-04-14
Aquisição de Medicamentos do foro oncológico e imunomoduladores, ao abrigo do acordo quadro 2023/491, para o ano 2025
PT · 11749193 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€144,806 2025-04-10
Aquisição de Tocilizumab 162 mg/0.9 ml caneta pré-cheia (Tyenne/FRESENIUS) BIOSSIMILAR, Tocilizumab 20 mg/ml Sol inj Fr 10 ml IV ((Tyenne/FRESENIUS) BIOSSIMILAR e Tocilizumab 20 mg/ml Sol inj Fr 4 ml IV (Tyenne/FRESENIUS) BIOSSIMILAR
PT · 11461043 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€146,245 2025-04-03
Aquisição de Medicamentos Oncológicos AQ 2023/491– Ano 2025
PT · 11316453 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,518 2025-03-28
VÁRIOS MEDICAMENTOS
PT · 11316574 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award
€19,154 2025-03-25
J1/852/2025 – Agregação Urgente - ADALIMUMAB - IDACIO - Doentes em tratamento – FRESENIUS
PT · 11317693 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€145,041 2025-03-14
DM CLINICO - SACO QUADRUPLO C/FILTRO DESLEUCOCITAÇÃO INCORPORADO P/SANGUE
PT · 12780910 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,152 2025-03-07
AQUISIÇÃO DE PRODUTOS FRESENIUS KABI PHARMA PORTUGAL, LDA
PT · 11394007 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,610 2025-02-28
MEDICAMENTOS
PT · 11313161 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,131 2025-02-21
Aquisição de Medicamentos diversos ao abrigo do CPA 2023/671 para a ULSASI para o ano 2025
PT · 11228301 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€148,488 2025-02-17
Aquisição de Dietas e Leites (2025-2027)
PT · 11428866 · Concurso público
A5 · Threshold Splitting A2 · Late Publication +1
€142,808 2025-02-11
PQ/514/2025 - SODIO, CLORETO 0,9% INJ-250ML
PT · 11624496 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€144,243 2025-02-10
Medicamentos diversos V
PT · 11317819 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,578 2025-02-10
Aquisição de Medicamentos à Fresenius Kabi Pharma - 2025 - ULSLO.
PT · 11481368 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€144,879 2025-01-22
PN/226/2025 -Medicação de nutrição
PT · 11541002 · Concurso público
A5 · Threshold Splitting A2 · Late Publication +1
€19,385 2025-01-17
Medicamentos
PT · 11324921 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,849 2025-01-08
Fornecimento de Medicamentos do Aparelho Geniturinário e Medicamentos para Nutrição Parentérica AQ 495/2023 e 493/2023
PT · 11514088 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,923 2025-01-06
MEDICAMENTOS
PT · 11130055 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,145 2024-12-18
Medicamentos Diversos
PT · 11224766 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting C3 · Missing Mandatory Fields
€4,878 2024-12-17
91/5194/2024 - Medicamento "Rocurónio" e Dieta Completa
PT · 11104142 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,754 2024-12-09
Q1/3583/2024 – Agregação Urgente – IRINOTECANO
PT · 11016427 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,990 2024-11-08
Artigos da Área Hospitalar
PT · 11040088 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication +1
€74,899 2024-10-21
Aquisição de Suplementos Orais
PT · 10990194 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication
€19,172 2024-09-26
VÁRIOS MEDICAMENTOS
PT · 10939039 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€74,555 2024-09-24
Next →
Overview
Total Value Won
€11,055,352,507
Contracts Won
9,435
Score 321065 · CRITICAL RISK
NIF
504293753
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.C. [P-648f]
    Gerente
    since 2011-03-04
  • A.C. [P-648f]
    Gerente
    since 2012-03-08
  • A.C. [P-648f]
    Gerente
    since 2013-05-29
  • A.C. [P-648f]
    Gerente
    since 2014-03-21
  • A.C. [P-648f]
    Gerente
    since 2016-01-20
  • A.C. [P-648f]
    Gerente
    since 2018-10-15
  • A.C. [P-648f]
    Gerente
    since 2020-03-30
  • A.M. [P-a213]
    Gerente
    since 2020-09-08
  • A.M. [P-a213]
    Gerente
    since 2023-11-09
  • A.M. [P-a213]
    Gerente
    since 2024-11-28
  • A.C. [P-ad9a]
    Gerente
    since 2009-12-11
  • F.F. [P-1c40]
    Gerente
    since 2020-09-08
  • F.F. [P-1c40]
    Gerente
    since 2023-11-09
  • F.F. [P-1c40]
    Gerente
    since 2024-11-28
  • F.J. [P-c0b7]
    Gerente
    since 2011-03-04
  • F.J. [P-c0b7]
    Gerente
    since 2013-05-29
  • F.J. [P-c0b7]
    Gerente
    since 2014-03-21
  • G.L. [P-6763]
    Gerente
    since 2018-10-15
  • G.L. [P-6763]
    Gerente
    since 2020-03-30
  • G.L. [P-6763]
    Gerente
    since 2020-09-08
  • G.L. [P-6763]
    Gerente
    since 2023-11-09
  • G.L. [P-6763]
    Gerente
    since 2024-11-28
  • H.J. [P-df65]
    Gerente
    since 2012-03-08
  • H.J. [P-df65]
    Gerente
    since 2013-05-29
  • H.J. [P-df65]
    Gerente
    since 2014-03-21
  • J.M. [P-a6dd]
    Gerente
    since 2016-01-20
  • J.M. [P-a6dd]
    Gerente
    since 2018-10-15
  • J.M. [P-a6dd]
    Gerente
    since 2020-03-30
  • K.A. [P-e283]
    Gerente
    since 2020-03-30
  • M.C. [P-3c40]
    Gerente
    since 2020-03-30
  • M.P. [P-b919]
    Gerente
    since 2016-01-20
  • M.P. [P-b919]
    Gerente
    since 2018-10-15
  • M.P. [P-b919]
    Gerente
    since 2020-03-30
  • P.A. [P-4562]
    Gerente
    since 2024-11-28
  • F.K. [P-11e0]
    Sócio
    since 2013-12-20
  • F.K. [P-d255]
    Sócio
    since 2013-12-20
  • A.C. [P-648f]
    Gerente
    2020-09-08 → 2021-11-19
  • H.J. [P-df65]
    Gerente
    2016-01-20 → 2016-05-16
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned